BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pasatru (garetosmab) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Pasatru (garetosmab)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07559513-145@assetmemo.bio
DTSTAMP:20261121T004943Z
DTSTART;VALUE=DATE:20300708
DTEND;VALUE=DATE:20300709
SUMMARY:Pasatru (garetosmab): Phase 3 readout est. (NCT07559513)
DESCRIPTION:Pasatru (garetosmab)\, phase 3\, Fibrodysplasia Ossificans Prog
 ressiva.\nStudy: A Study to Investigate the Safety\, Pharmacokinetics (PK)
 \, and Efficacy of Garetosmab in Children and Adolescents With Fibrodyspla
 sia Ossificans Progressiva (FOP)\nEstimated primary completion: 8 July 203
 0. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/garetosmab#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07559513
URL:https://assetmemo.bio/drug/garetosmab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
